Effect of Aparajita tablet against Yashtimadhu tablet in mild cognitive impairment
Not Applicable
- Conditions
- Health Condition 1: F068- Other specified mental disorders due to known physiological condition
- Registration Number
- CTRI/2022/04/041903
- Lead Sponsor
- Anjali A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Diagnosed cases of Mild Cognitive Impairment as per DSM V diagnostic criteria.
b) Age between 50-70 years.
c) Those willing to give written consent.
d) Those whose MMSE Score lies between 19-23.
e) Those who diagnosed with Type II Diabetes Mellitus.
f) No discrimination of gender, religion and economic status.
Exclusion Criteria
a) Subjects who have decline in cognitive functions as a result of trauma, surgery
cardiovascular diseases, stroke, thyroid dysfunction, chronic kidney diseases,
chronic liver diseases.
b) Those having major psychiatric co-morbidities.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacies of Apar�?jita cÅ«rÅ?a and Yaá¹£á¹imadhu cÅ«rÅ?a in Mild Cognitive Impairment by using MMSE <br/ ><br>To compare the Quality of Life of subjects with Mild Cognitive Impairment in study and <br/ ><br>control groups. <br/ ><br>Timepoint: Three months
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil